Brian Perkinson, MD
Adult Reconstructive Orthopaedic Surgery · Franklin, TNNPI 1548485071
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.6%), other and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Stryker at 54.5% of the total. Reporting peaked in 2024 at $130,869 and has fallen 84.1% since, to $20,750 in 2025.
Across 249 payments — averaging $919.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$125K
- Zimmer Biomet$103K
- Innovation Technologies Inc$135
- Johnson & Johnson$124
- Mallinckrodt Enterprises LLC$103
- Convatec Inc.$42
- plus $185 from 9 others
What the payments were for
- Consulting fees$104,32546%
- Travel & lodging$14,2376%
- Food & beverage$6,8773%
- Other$103,49345%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 232 | $124,850 |
| Zimmer Biomet | 1 | $103,493 |
| Innovation Technologies Inc | 3 | $135 |
| Johnson & Johnson | 1 | $124 |
| Mallinckrodt Enterprises LLC | 1 | $103 |
| Convatec Inc. | 1 | $42 |
| Conformis, Inc. | 1 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Alpha Orthopedic Systems | 1 | $28 |
| Vertex | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| CMS Imaging, Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
| Sanara Medtech Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$228,932 in reported general payments places this provider in the 85th percentile of 27 adult reconstructive orthopaedic surgery providers in Tennessee.
See all adult reconstructive orthopaedic surgery providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 70 | $1,403 |
| Meloxicam | 140 | $495 |
| Celecoxib | 26 | $426 |
| Methylprednisolone | 44 | $305 |
| Amoxicillin | 204 | $200 |
| Clindamycin Hcl | 56 | $74 |
| Cephalexin | 37 | $69 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Franklin
- Cory CalendineFranklin$2.5M
- William KurtzBrentwood$774K
- Conrad IvieKnoxville$609K
- Andrew ShinarNashville$151K
- William CarpenterNashville$146K
- Mark FreemanChattanooga$84K
- Christopher HollandGermantown$71K
- Larry JohnsonJackson$55K
- Matthew ChristieNashville$47K
- Justin KennonKnoxville$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.